Craig R. Rayner is PRESIDENT, INTEGRATED DRUG DEV of Certara, Inc.. Currently has a direct ownership of 316,010 shares of CERT, which is worth approximately $4.37 Million. The most recent transaction as insider was on Sep 02, 2021, when has been sold 54,462 shares (Common Stock) at a price of $35.38 per share, resulting in proceeds of $1,926,866. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 316K
0% 3M change
0% 12M change
Total Value Held $4.37 Million

Craig R. Rayner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 02 2021
SELL
Open market or private sale
$1,926,866 $35.38 p/Share
54,462 Reduced 14.7%
316,010 Common Stock
Jun 11 2021
SELL
Open market or private sale
$2,832,024 $26.0 p/Share
108,924 Reduced 22.72%
370,472 Common Stock
Apr 01 2021
BUY
Grant, award, or other acquisition
-
23,810 Added 4.87%
464,744 Common Stock
CRR

Craig R. Rayner

PRESIDENT, INTEGRATED DRUG DEV
Princeton, NJ

Track Institutional and Insider Activities on CERT

Follow Certara, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERT shares.

Notify only if

Insider Trading

Get notified when an Certara, Inc. insider buys or sells CERT shares.

Notify only if

News

Receive news related to Certara, Inc.

Track Activities on CERT